The University of Michigan Center for Value-Based Insurance Design (V-BID), in collaboration with a group of healthcare stakeholders, has announced the details of V-BID X, a template for reducing cost sharing for certain high-value services and raising cost sharing for certain low-value services while not increasing premiums or deductibles.
The University of Michigan Center for Value-Based Insurance Design (V-BID), in collaboration with a group of healthcare stakeholders, has announced the details of V-BID X, a template for reducing cost sharing for certain high-value services and raising cost sharing for certain low-value services while not increasing premiums or deductibles.
The cost-neutral template will serve as a new plan option for the individual health insurance market. VBID principles, which align patient cost sharing with the value of a select service, has gained traction in recent years, with CMS expanding the VBID demonstration in Medicare Advantage to all 50 states. However, several challenges, including a lack of standardization, have created barriers to more widespread implementation of VBID. V-BID X hopes to address and mitigate these challenges.
“While we’ve had some implementation in the private sector, in the Medicare program, and the Tricare program, implementation of VBID has slowed for a number of reasons,” said The American Journal of Managed Care®’s (AJMC®’s) co-editor-in-chief A. Mark Fendrick, MD, professor of medicine in the School of Medicine, professor of health management and policy in the School of Public Health, and director of the VBID Center at the University of Michigan, during a webinar introducing the template.
“I think 2 that are most notable are lack of a standard VBID plan, and there’s been a lot of concern regarding the cost impact or the return on investment that comes with the increased utilization of high-value services, particularly those whose cost sharing is lowered in a VBID high-value service type model,” he added.
Collaborating with Covered California, Blue Cross Blue Shield Association, America’s Health Insurance Plans, Massachusetts Health Connector, and CMS, the V-BID Center came up with guiding principles plans to identify high- and low-value services, including:
Following the guiding principles, stakeholders created the first iteration of VBID X, which included 9 high-value services with no cost sharing:
The template also contains high-value generic drugs with no cost sharing, with the first iteration including antiretrovirals for HIV, anti-depressants, antipsychotics, statins, beta blockers, and naloxone, as well as high-value branded drugs with reduced cost sharing, including pre-exposure prophylaxis for HIV, hepatitis C direct-acting agents, and anti-TNF agents.
Specific low-value services include spinal fusions, vertebroplasty and kyphoplasty, vitamin D testing, and proton beam for prostate cancer.
Commonly overused service categories identified by working groups include:
During the webinar, AJMC® co-editor-in-chief Michael E. Chernew, PhD, Leonard D. Schaeffer Professor of Health Care Policy and director of Healthcare Markets and Regulation Lab at Harvard Medical School, emphasized that the identified services represent just 1 version of what a plan could look like, with payers having significant flexibility in how they can design their version of V-BID X to fit their populations by selecting high- and low-value services and then determining the reduction or increase in cost sharing for those services and determining the actuarial value of the plan.
“Whether or not the numbers balance in your population will depend on the characteristics and the utilization patterns of your population,” he explained.
Beyond Insulin: The Impact of Next-Generation Diabetes Technology
April 17th 2024Experts explain how new diabetes technologies like continuous glucose monitors are transforming care beyond intensive insulin therapy, offering personalized insights and improving outcomes for patients of all treatment levels.
Read More
How Can Employers Leverage the DPP to Improve Diabetes Rates?
February 15th 2022On this episode of Managed Care Cast, Jill Hutt, vice president of member services at the Greater Philadelphia Business Coalition on Health, explains the Coalition’s efforts to reduce diabetes rates through the Diabetes Prevention Program (DPP).
Listen
Challenges, Adaption Needed in Conducting Research for Homeless Youth Living With HIV
April 8th 2024HIV testing, treatment, and intervention session delivery were among some areas that saw challenges in properly addressing youth experiencing homelessness during an HIV prevention trial.
Read More
Balancing Care Access and Fragmentation for Better Outcomes in Veterans With Diabetes
April 22nd 2021The authors of a study in the April 2021 issue of The American Journal of Managed Care® discuss the possible reasons behind the link between care fragmentation and hospitalizations in veterans with diabetes, as well as potential opportunities to address disjointed care in the context of the widespread telehealth uptake seen during the COVID-19 pandemic.
Listen